e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Epidemiology and risk factors in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of beta2-agonists in the formation of carbohydrate metabolism disorders in the patients with asthma
I. V. Liverko (Tashkent, Uzbekistan)
Source:
Annual Congress 2005 - Epidemiology and risk factors in asthma
Session:
Epidemiology and risk factors in asthma
Session type:
Poster Discussion
Number:
4327
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. V. Liverko (Tashkent, Uzbekistan). Role of beta2-agonists in the formation of carbohydrate metabolism disorders in the patients with asthma. Eur Respir J 2005; 26: Suppl. 49, 4327
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The rate of carbohydrate metabolism disorders in the patients with bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Effect of carbohydrate metabolism disturbances on tolerence of physical load in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 638s
Year: 2006
The pharmacogenetic aspects of corticosteroid metabolism in patients with severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 523s
Year: 2006
Sensitivity and reactivity to exogenous insulin in the diagnosis of carbohydrate disorders in patients with bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 420s
Year: 2003
Sensitivity and reactivity to exogenous insulin in the diagnosis of carbohydrate disorders in patients with bronchial asthma
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Features of carbohydrate metabolism in patients with COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Inhaled corticosteroids and β
2
-agonists reduces imbalance in the cellular redox status in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004
Peculiarities of calcium-phosphorus metabolism and lung function in patients with bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 420s
Year: 2003
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance
Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Year: 2010
Clinical problems of comorbidity from a position of COPD and carbohydrate metabolism disorders
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
Carbohydrate metabolism state in COPD patients
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010
Role of Pgp in corticosteroid sensitivity in patients with severe forms of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
Features of chronic cough in patients with oxalate metabolism disorders
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy
Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Year: 2006
Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of
IL13
with asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
The role of response to bronchodilators in differential diagnosis of COPD and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 424s
Year: 2003
Impaired glucose homeostasis in children with acute exacerbation of asthma is transitory
Source: Eur Respir J 2001; 18: Suppl. 33, 42s
Year: 2001
Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept